94 filings
Page 5 of 5
8-K
g84733rkjbmutm3xd0t4
11 Feb 14
Departure of Directors or Certain Officers
12:00am
8-K
c27vcbwy2ogtv2mwmkp
7 Feb 14
Submission of Matters to a Vote of Security Holders
12:00am
8-K
ql1t lm9hw
4 Feb 14
Departure of Directors or Certain Officers
12:00am
8-K
gnob4y2ilo5it5i
31 Jan 14
Other Events
12:00am
8-K
b71 2gx4x5300s
10 Jan 14
Departure of Directors or Certain Officers
12:00am
8-K
eojqic wicx5
10 Dec 13
Enanta Pharmaceuticals Announces 96 Percent SVR12 in Treatment Experienced Genotype 1 hepatitis C Patients in SAPPHIRE-II Study
12:00am
8-K
si4p91gux0j8h0 6y
26 Nov 13
Departure of Directors or Certain Officers
12:00am
8-K
j1tfa2i51n
25 Nov 13
Results of Operations and Financial Condition
12:00am
8-K
2l7 sxi7js
18 Nov 13
Enanta Pharmaceuticals Announces 96 Percent SVR12 in SAPPHIRE-I Study
12:00am
8-K
vm5zcl
3 Sep 13
Entry into a Material Definitive Agreement
12:00am
8-K
f4r3asj
21 Aug 13
Departure of Directors or Certain Officers
12:00am
8-K
ege f9chygnsuf3a9
12 Aug 13
Results of Operations and Financial Condition
12:00am
8-K
heriji7fial 0m
8 May 13
Results of Operations and Financial Condition
12:00am
8-K
ptibllb0utw1os0
28 Mar 13
Amendments to Articles of Incorporation or Bylaws
12:00am